Medtronic recalls InPen App version 7.5.0-8.0.0 for Android users. Uninstalling and reinstalling resets notification permissions, risking missed insulin alerts and hyperglycemia.
When app is uninstalled and reinstalled, insulin pen software issue causes Choose Notification Style Screen to not show during setup so users can't choose to allow notifications to override phone settings when on mute/Do Not Disturb, and previously set up override permission is deleted, so audible and vibratory notifications not received, which may lead to delayed insulin therapy, hyperglycemia.
Medtronic is recalling its InPen App for Android users with model numbers MMT-8061. The app may reset notification permissions when uninstalled and reinstalled, causing users to miss insulin alerts and potentially leading to high blood sugar levels.
When the app is uninstalled and reinstalled, it deletes previously set notification permissions. This means users can't receive audible or vibratory alerts when their phone is on mute or Do Not Disturb mode, which could delay insulin therapy and cause high blood sugar levels.
Android users with Medtronic InPen App version 7.5.0, 7.5.1, or 8.0.0. People with diabetes who rely on the app for insulin alerts are most at risk.
Check your InPen App version in the app store. The affected model is MMT-8061 with software versions 7.5.0, 7.5.1, and 8.0.0. The UDI-DI number is 00763000974596.
Look for the app version in the Google Play Store or Apple App Store to confirm if it's 7.5.0, 7.5.1, or 8.0.0.
Update to the latest version of the InPen App to fix notification permissions.
The recall happens because uninstalling and reinstalling the app resets notification permissions, which can cause users to miss insulin alerts when their phone is on mute or Do Not Disturb mode.
No action is needed if you don't use the InPen App or have a different app version.
Uninstalling and reinstalling the app will delete previously set notification permissions, so you may miss insulin alerts if your phone is on mute or Do Not Disturb mode.
We’ve drafted a message you can send Medtr: a short, human brand name for headings (e.g. "Trsmima") to request your refund or repair — edit it as you like.
Subject: Recall Z-0958-2026 — Medtr: a short, human brand name for headings (e.g. "Trsmima") Medtr: a short, human brand name for Hello, I own a Medtr: a short, human brand name for headings (e.g. "Trsmima") that is covered by recall Z-0958-2026 from Medtr: a short, human brand name for headings (e.g. "Trsmima"). I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
